SCHEMBL4757410

SCHEMBL4757410

CS(=O)(=O)Nc1nc(NC(=O)c2cccc(F)c2O)sc1Cl

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.42
RAB9A P51151 7/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
TP53 P04637 2/20 0.42
PKM P14618 2/20 0.42
ALOX15 P16050 1/20 0.42
HTT P42858 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
RXFP1 Q9HBX9 2/20 0.40
ALDH1A1 P00352 1/20 0.40
GRM4 Q14833 4/20 0.40
P2RX1 P51575 1/20 0.40
P2RX7 Q99572 1/20 0.40
POLB P06746 2/20 0.39
MAPT P10636 3/20 0.39
GAA P10253 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757405 0.79 MEN1 (0.46) NPC1RAB9ASMN1; SMN2TP53PKM
SCHEMBL29870 0.68 HSD17B1 (0.75) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL4757378 0.68 NPC1 (0.55) NPC1RAB9ASMN1; SMN2TP53HTT
SCHEMBL10114188 0.68 RAB9A (0.51) NPC1RAB9ASMN1; SMN2TP53PKM
SCHEMBL4757428 0.67 NPC1 (0.42) NPC1RAB9ASMN1; SMN2TP53PKM
SCHEMBL4756736 0.67 P2RX1 (0.43) NPC1RAB9AMEN1KMT2ARXFP1
SCHEMBL4756596 0.66 CRHBP (0.66) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL4757380 0.65 STAT3 (0.46) NPC1RAB9ASMN1; SMN2HSD17B10MEN1
SCHEMBL9343198 0.63 KMT2A (0.66) NPC1RAB9ASMN1; SMN2TP53HTT
SCHEMBL4756535 0.63 RAB9A (0.57) NPC1RAB9ASMN1; SMN2TP53HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC NPC1 585/4885RAB9A 1694/4885SMN1; SMN2 3410/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC NPC1 585/4885RAB9A 1694/4885SMN1; SMN2 3410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.